A new study shows that antibodies from Long COVID patients can induce persistent pain-like symptoms in mice. This provides evidence for a potential causal role of autoantibodies in Long Covid.
Researchers have successfully repurposed an FDA-approved cancer drug, doxorubicin, to treat drug-resistant strains of herpes. A digital tool that combs through chemical compounds and flags those that may be effective against herpes infections, identified doxorubicin, a known anticancer drug.
The Global Virus Network (GVN) today announced the recipients of $90,000 in 2025 Education and Training Grants, supporting emerging scientists and institutions advancing translational virology, genomic surveillance, data-driven preparedness, and global health equity.
On World TB Day, WHO is urging countries to accelerate action to end tuberculosis (TB) and expand access to lifesaving services by using new innovations such as diagnostic tests that can be used near the point-of-care and tongue swabs that can help detect the disease faster.
Scientists have found evidence that the spread of AMR isn’t always driven by bacteria evolving to resist the antibiotics themselves: rather, certain weedkillers can have the same effect.
UK-BASED cleanroom engineering company Total Clean Air (TCA), a UKAS ISO 17025-accredited cleanroom constructor, has been appointed European partner for US-based decontamination technology firm TOMI®Environmental Solutions.
A new study shows that antibodies from Long COVID patients can induce persistent pain-like symptoms in mice. This provides evidence for a potential causal role of autoantibodies in Long Covid.
Researchers have successfully repurposed an FDA-approved cancer drug, doxorubicin, to treat drug-resistant strains of herpes. A digital tool that combs through chemical compounds and flags those that may be effective against herpes infections, identified doxorubicin, a known anticancer drug.
Scientists have found evidence that the spread of AMR isn’t always driven by bacteria evolving to resist the antibiotics themselves: rather, certain weedkillers can have the same effect.
UK-BASED cleanroom engineering company Total Clean Air (TCA), a UKAS ISO 17025-accredited cleanroom constructor, has been appointed European partner for US-based decontamination technology firm TOMI®Environmental Solutions.
EnteroBiotix announced that the investigator-initiated Phase 2a MAST trial has completed its enrolment of 50 adult patients undergoing allogeneic haematopoietic stem cell transplantation (allo-HSCT) for defined haematological malignancies.
Thermo Fisher Scientific today announced the launch of Thermo Scientific™ Brilliance™ Candida 2 Agar and Spectra™ Candida Agar, new color-based (chromogenic) culture media to help laboratories quickly detect and differentiate clinically important Candida species.
Biomedical engineers have developed a new wound dressing material that releases antibiotic drugs only when harmful bacteria are present in a wound. The material could help rapidly clear wound infections to accelerate healing while reducing the unnecessary use of antibiotics.
New research describes a novel chemical mixture for sanitation in low-moisture environments. Scientists found that a formulation containing cyclomethicone combined with vinegar-based acetic acid was the most effective against Salmonella and Cronobacter bacteria.
A study shows how molecules that are only broken down by infecting bacteria, and not by gut bacteria, can be used to confirm infection. By enriching these molecules with a naturally occurring carbon isotope, the researchers found that carbon dioxide produced when they break down is easily detected in a breath test.
The Global Virus Network (GVN) today announced the recipients of $90,000 in 2025 Education and Training Grants, supporting emerging scientists and institutions advancing translational virology, genomic surveillance, data-driven preparedness, and global health equity.
On World TB Day, WHO is urging countries to accelerate action to end tuberculosis (TB) and expand access to lifesaving services by using new innovations such as diagnostic tests that can be used near the point-of-care and tongue swabs that can help detect the disease faster.
The University of Warwick has announced that it has received a £1.2 million donation to further antimicrobial resistance research from alumnus Dr David Stirling (PhD Biosciences, 1974-78). The generous contribution forms part of Warwick’s Set the Pace philanthropic campaign.